How to individualize therapy after failing milestones in chronic myeloid leukaemia : weighting late response and early death from CML against risk of alternative therapies
| Errataetall: |
CommentOn: Leukemia. 2023 Nov;37(11):2324-2325. - PMID 37798329 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Leukemia - 38(2024), 2 vom: 11. Feb., Seite 465-466 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hehlmann, Rüdiger [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.02.2024 Date Revised 29.03.2024 published: Print-Electronic CommentOn: Leukemia. 2023 Nov;37(11):2324-2325. - PMID 37798329 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41375-024-02139-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367092859 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367092859 | ||
| 003 | DE-627 | ||
| 005 | 20240330000749.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-024-02139-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM367092859 | ||
| 035 | |a (NLM)38218735 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hehlmann, Rüdiger |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How to individualize therapy after failing milestones in chronic myeloid leukaemia |b weighting late response and early death from CML against risk of alternative therapies |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.02.2024 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Leukemia. 2023 Nov;37(11):2324-2325. - PMID 37798329 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 700 | 1 | |a Lauseker, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 38(2024), 2 vom: 11. Feb., Seite 465-466 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:2 |g day:11 |g month:02 |g pages:465-466 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-024-02139-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2024 |e 2 |b 11 |c 02 |h 465-466 | ||